
Economic Analysis of Panitumumab Compared With Cetuximab in Patients With Wild-type KRAS Metastatic Colorectal Cancer That Progressed After Standard Chemotherapy
Keywords: سرطان روده بزرگ; cetuximab; colorectal cancer; cost-effectiveness; cost-minimization; panitumumab; subsequent-line;